Systematic review compares treatment effects on dry eye disease, highlighting differences in patient outcomes.
This study revealed that CsA and DQS did not differ significantly in their efficacy in improving most objective clinical indices for DED over 1-3 months of treatment. However, DQS demonstrated greater improvement in subjective patient-reported outcomes. Future RCTs should explore the long-term efficacy of these treatments.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: